Charmacy Pharmaceutical Co., Ltd. (SEHK: 2289)
Health Care · Health Care Providers & Services · CN
HK$5.50
-0.09% today · -5.7% 1Y
Charmacy Pharmaceutical Co., Ltd. (SEHK: 2289) operates in the Health Care Providers & Services industry within the Health Care sector. The company is valued at $75.62M and employs 827 people.
Over the last twelve months the share price has lost 5.7%, trading between 4.30 and 7.40.
Tweenvest scores Charmacy Pharmaceutical Co., Ltd. across four factors: quality 66/100, value 72/100, growth 7/100, dividend 100/100. Its strongest factor is dividend.
2289 price history
Not enough price history to draw a chart yet.
Key figures
- Market cap
- $75.62M
- Revenue (TTM)
- $688.62M
- P/E
- 10.92
- EPS
- 0.44
- Dividend yield
- 6.40%
- Beta (5Y)
- -0.96
- 52-week high
- HK$7.40
- 52-week low
- HK$4.30
- Avg volume (3M)
- —
- Shares outstanding
- 108.00M
- Employees
- 827
- Next earnings
- —
About Charmacy Pharmaceutical Co., Ltd.
Charmacy Pharmaceutical Co., Ltd. serves as a prominent distributor of pharmaceutical products across the People's Republic of China. The company's comprehensive portfolio includes Western medications, traditional Chinese patent medicines, and various healthcare items, along with associated advisory services. These are supplied to both wholesale distributors and retail pharmacies. Furthermore, Charmacy operates "Charmacy e-Medicine," its proprietary B2B digital platform, which enables clients to efficiently place orders, make inquiries, and process payments online. Founded in 1984, the firm maintains its headquarters in Shantou, PRC. It was formerly known as Chuangmei Pharmaceutical Co., Ltd. until its official renaming to Charmacy Pharmaceutical Co., Ltd. in July 2016.
- ISIN
- CNE1000023D6
- Founded
- 1984
- Listed since
- Dec 14, 2015
- Exchange
- The Stock Exchange of Hong Kong Ltd.
- Currency
- HKD
Other Health Care Providers & Services companies
| Company | Market cap | Price | Day |
|---|---|---|---|
| WOLVES HAND Co., Ltd.TSE: 194A | $77.20M | ¥1,616.00 | -5.00% |
| Professional Medical Expertise CompanySASE: 9574 | $76.53M | SR82.10 | -0.48% |
| Ratchaphruek Hospital Public Company LimitedSET: RPH | $76.51M | ฿4.84 | -0.41% |
| Ladprao General Hospital Public Company LimitedSET: LPH | $75.78M | ฿3.60 | -0.55% |
| Focus Point Holdings BerhadKLSE: FOCUSP | $75.23M | RM0.50 | -0.99% |
| The Lanka Hospitals Corporation PLCCOSE: LHCL.N0000 | $74.74M | SLRs110.50 | -3.91% |
| Aptus Pharma LimitedBSE: 544529 | $74.67M | Rs421.40 | +16.80% |
| HAEMATO AGHMSE: HAEK | $74.34M | €12.70 | -2.31% |
Figures last refreshed Oct 11, 2026.